Skip to main content
. 2024 Nov 15;13(22):6875. doi: 10.3390/jcm13226875

Table 2.

Demographic characteristics and disease distributions of monoclonal gammopathies in each immunoglobulin isotype.

Disease Categorization n = 863 Type (κ/λ) Sex (M/F) Age (Years) MP Level (g/dL)
IgG Total 559 (100.0) 337/222 319/240 71 (31–94) 2.59 (0.03–9.45)
Multiple myeloma * 369 (66.0) 228/141 190/179 70 (37–93) 3.70 (0.13–9.45)
Solitary plasmacytoma 13 (2.3) 7/6 9/4 60 (46–76) 0.95 (0.19–2.31)
Amyloidosis 6 (1.1) 3/3 4/2 71 (31–76) 1.46 (0.90–2.90)
Mature lymphoid neoplasm 3 (0.5) 3/0 2/1 59 (58–68) 1.05 (0.09–1.09)
LPM, unspecified 4 (0.7) 1/3 3/1 79 (49–82) 5.30 (3.24–8.17)
MGCS 12 (2.2) 3/9 11/1 71.5 (62–85) 0.86 (0.20–2.35)
MGUS 152 (27.2) 92/60 100/52 73 (32–94) 0.73 (0.03–2.93)
IgA Total 165 (100.0) 95/70 90/75 70 (47–86) 2.74 (0.01–8.84)
Multiple myeloma * 126 (76.4) 78/48 66/60 70 (49–86) 3.49 (0.24–8.84)
Amyloidosis 4 (2.4) 1/3 2/2 74.5 (66–78) 1.18 (0.11–1.43)
LPM, unspecified 1 (0.6) 0/1 0/1 76 (76–76) 4.35 (4.35–4.35)
MGCS 1 (0.6) 1/0 1/0 57 (57–57) 1.43 (1.43–1.43)
MGUS 33 (20.0) 15/18 21/12 69 (47–85) 0.71 (0.01–1.42)
IgM Total 68 (100.0) 56/12 50/18 71.5 (42–90) 1.20 (0.02–6.67)
Multiple myeloma * 2 (2.9) 2/0 2/0 70.5 (64–77) 3.84 (1.07–6.60)
WM 41 (60.3) 38/3 33/8 70 (42–88) 2.26 (0.57–6.67)
Amyloidosis 1 (1.5) 1/0 1/0 85 (85–85) 0.41 (0.41–0.41)
Mature lymphoid neoplasm 4 (5.9) 4/0 1/3 70 (64–75) 0.76 (0.40–5.80)
LPM, unspecified 1 (1.5) 0/1 1/0 83 (83–83) 4.58 (4.58–4.58)
MGCS 2 (2.9) 1/1 1/1 75 (74–76) 0.34 (0.30–0.38)
MGUS 17 (25.0) 10/7 11/6 72 (58–90) 0.29 (0.02–1.26)
FLC Total 71 (100.0) 19/52 43/28 68 (33–89) 0.40 (0.02–6.54)
Multiple myeloma * 63 (88.7) 14/49 36/27 70 (33–89) 0.43 (0.03–6.54)
Solitary plasmacytoma 1 (1.4) 1/0 0/1 57 (57–57) 0.20 (0.20–0.20)
MGUS 7 (9.9) 4/3 7/0 65 (50–82) 0.27 (0.02–0.88)

Data are n (%), n/n, or median (range) values. * Smouldering multiple myeloma and plasma cell leukemia were included. Abbreviations: MP, monoclonal protein; LPM, lymphoplasmacytic malignancy; MGCS, monoclonal gammopathy of clinical significance; MGUS, monoclonal gammopathy of undetermined significance; WM, Waldenström’s macroglobulinemia; FLC, free light chain.